Anuradha Enterprises

• Single test for identifying acute infection and protective immunity by detecting and differentiating IgG and IgM anti-HAV
• Indicates protective immunity by detecting HAV IgG titers ≥70 mIU/mL
• High confidence as it is traceable to the 2nd WHO International Standard for HAV, and IgM is in agreement with market leading ELISA test: Sensitivity: 94.8%; Specificity: 96.7%
• Flexible specimen types including serum, plasma, or whole blood which allows testing at any time without special specimen preparation
• Small sample volume (5 µL) enables multiple testing on the same specimen without having to re-draw the patient.
• Initial patient care action can begin during the patient’s visit as test results are available in 15 minutes.
• Easily transported, and can be stored for 24 months at 2-30oC

Products available as per the customer requirement, Our products is highly appreciated by customers.
Merilisa HIV Gen 4 is an enzyme immunoassay for the qualitative determination of HIV p24 antigen and antibodies to Human Immunodeficiency Virus type 1 (HIV-1) and type 2 (HIV-2) in human serum or plasma. Merilisa HIV Gen 4 detects HIV p24 antigen in addition to IgG, IgA and IgM antibodies to the core and envelope glycoproteins of HIV 1-2 by using p24 monoclonal antibodies and recombinant proteins of gp41, gp120 and gp36 representing the immunodominant regions of HIV 1-2

Products available as per the customer requirement, Our products is highly appreciated by customers.

• Products available as per the customer requirement, Our products is highly appreciated by customers.

Products available as per the customer requirement, Our products is highly appreciated by customers.Product should be stored at 2-8 °C.
Precautions
Potential biohazardous materials:
The calibrator and controls contain human source components, which have been tested and found non-reactive for hepatitis B surface antigen as well as HIV antibody with FDA licensed reagents.  However, as there is no test method that can offer complete assurance that HIV, Hepatitis B virus or other infectious agents are absent, these reagents should be handled at the Biosafety Level 2, as recommended in the Centers for Disease Control/National Institutes of Health manual, "Biosafety in Microbiological and Biomedical Laboratories." 1984
This test kit is designed for Research Use Only.
Do not pipette by mouth. Do not smoke, eat, or drink in the areas in which specimens or kit reagents are handled.
The components in this kit are intended for use as an integral unit.  The components of different lots should not be mixed.
It is recommended that serum samples be run in duplicate.
Optimal results will be obtained by strict adherence to this protocol.  Accurate and precise pipetting, as well as following the exact time and temperature requirements prescribed are essential.  Any deviation from this may yield invalid data.
References
all, E., Methods in Enzymology, Volume 70, Van Vunakis, H.  and Langone, J. J. (eds.), Academic Press, New York, 419- 492   (1980).
tila, M., Ruoslahti, E. and Engvall, E., J. lmmunol. Methods, 42, 11-15 (1981).
Kenemans P, Yedema CA, Bon GG, von Mensdorff-Pouilly S. Ca125 in gynecological pathology a review. Eur J Obstet Gynecol 1993;49:115-124.
Saksela F. Prognostic markers in epithelial ovarian cancer. Intl J Gynecol Pathol 1993;12:156-161.
Farghaly SA. Tumor markers in gynecologic cancer. Gynecol & Obstet Invest 1992;34:65-72.
Welander CE. What do CA 125 and other antigens tell us about ovarian cancer biology. Acta Obstet Gynecol Scand Sup 1992;155:85-93.
McGowan L. Pathology of the ovary. Curr Opin on Obstet Gynecol 1991;3:580-586.
Niloff JM. Ovarian malignancy. Curr Opin on Obstet Gynecol 1991;3:66-72.
Olt G, Berchuck A, Bast RC. The role of tumor markers in gynecologic oncology. Obstet Gynecol Survey 1990;45-:570-577.
Diez M, Cerdan FJ, Ortega MD, Torres A, Picardo A, Balibrea JL. Evaluation of serum CA125 as a tumor marker in non-small cell lung cancer. Cancer 1991;67:150-154.
Niloff JM, Klug TL, Schaetzl E. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. AM J. Obstet Gynecol 1984; 148:1057